Dantrolene sodium 100 mg Oral Capsule
RxNorm 856652
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 856652 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dantrolene sodium 100 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Dantrolene sodium 100 mg Oral Capsule
(Atom ID: 12330635)
PSNPrescribable
Prescribable Name (PSN):
Dantrolene sodium 100 mg Oral Capsule
(Atom ID: 6360457)
PTPrescribable
Designated preferred name (PT):
Dantrolene sodium 100 mg oral capsule
(Atom ID: 10296849)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely dantrolene sodium 100 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10311127)
Patient Education
Dantrolene
Dantrolene is used to treat spasticity (muscle stiffness and tightness) or muscle spasms associated with spinal cord injuries, stroke, multiple sclerosis, or cerebral palsy. It is also used to prevent, treat, or reduce the risk of malignant hyperthermia (disorder that causes a fast rise in body temperature and muscle contractions), Dantrolene is in a class of medications called skeletal muscle relaxants. Dantrolene acts on the spinal cord nerves to treat spasticity and to prevent and treat malignant hyperthermia.
[Learn More]
* Please review the disclaimer below.